Victor Grifols Deu

Grifols Diagnostic Solutions, Inc. manufactures and markets plasma medicines and medical tools. Its services include blood group genotyping testing, IRL serology testing, prenatal testing, biological drug monitoring tests, FH genetic testing and other genetic testing. The company is headquartered in Emeryville, CA.

Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA.

Medion Grifols Diagnostics AG engages in the development, production, and distribution of biotechnological and diagnostic products. The company was founded on February 10, 2006 and is headquartered in Duedingen, Switzerland.

BRAINco Biopharma SL develops and produces diagnosis and treatment for neurological and psychiatric diseases. It develops drugs directed against therapeutic targets and diagnostic biochips, prognosis, and prediction of individual response to drug treatment. The company was founded by Laureano Simon Buela in 2008 and is headquartered in Bilbao, Spain.

Tojosnura SL provides legal services. The company was founded by Tomas Daga Gelabert and is headquartered in Barcelona, Spain.

Part of Grifols SA, Squadron Reinsurance DAC is an Irish company that provides reinsurance services. The company is based in Dublin, Ireland.

Part of Grifols SA, Grifols UK Ltd. is a company that sells diagnostic instruments and reagents & automated blood-typing systems. The company is based in Cambridge, UK. The British company was founded in 1901. The CEO is Paula Karen Blackmore.

Arrahona Optimus SL engages in acquisition, sale of all types of real estate, administration, operation and urban development of land. The company was incorporated on May 31, 2005 and is headquartered in Barcelona, Spain.

Part of Theriva Biologics, Inc., VCN Biosciences SL is a clinical-stage immuno-oncology company based in Barcelona, Spain. The Spanish company focuses on developing the next generation of oncolytic adenoviruses that can obtain clinical activity after systemic administration and remodel the complex matrix in the tumor to allow enhanced spreading of therapeutic molecules and the immune system. VCN Biosciences' lead product, VCN-01, is a unique oncolytic adenovirus being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma. The company was founded by Ramon Alemany. VCN Biosciences was acquired by Theriva Biologics, Inc. from Grifols SA on March 10, 2022 for $92.02 million.

Grifols Worldwide Operations USA, Inc. engages in the distribution of plasma. The company is headquartered in City of Industry, CA.

Grifols Shared Services North America, Inc. manufactures plasma derivative biopharmaceutical products. Its divisions include bioscience, hospital and diagnostic. The company is headquartered in Los Angeles, CA.

Probitas Foundation promotes and finances various activities and cooperative programs to improve healthcare. The private company is based in Barcelona, Spain.

Farmafluid SA is a Spanish company that manufactures and supplies cosmetics and perfume products. The private company is based in Madrid, Spain.

Osborne Clarke Advokatfirma AB is a legal firm that specializes in providing legal advice on data protection, security, cyber, and privacy-related issues. Osborne Clarke Advokatfirma is based in Stockholm, SE. The Swedish company helps retail and consumer brands achieve their commercial objectives and vision. The private company has a proven reputation and extensive experience of working with some of the world's biggest brands and fastest-moving organizations in the sectors of food & beverage, fashion, luxury & beauty, consumer goods, and retail chains.

Part of Grifols SA, Grifols Canada Ltd. is a Canadian company committed to quality, safety, and innovation. The company is based in Mississauga, Canada. Grifols Canada is taking a multimodal approach to slow Alzheimer's progression with their AMBAR® procedure. The company was founded in 1909 by Josep Antoni Grifols, and the CEOs are Raimon Grifols Roura and Víctor Grifols Roura.